July 20, 2017 / 4:59 AM / a month ago

BRIEF-India's Natco Pharma gets EIR from U.S. FDA

July 20 (Reuters) - Natco Pharma Ltd:

* Says receives Establishment Inspection Report (EIR) from U.S. Food and Drug administration

* Inspection was conducted at its drug formulations facility at Kothur unit, Telangana during Jan 16 to Jan 24

Source text for Eikon:

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below